Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis

Links shared publicly online about this topic.

  • 0
    total visits

Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis

medicalnewstoday.com

A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis.

View full resource at medicalnewstoday.com

Tags: Allergy and Immunology, Crohn's Disease Medication, Lupus, Kidney Disease, Drug, Imuran, Nephritis

  • Share

Most Recently Shared on November 17, 2011 at 11:05 am By:

mnt_lupus MNT Lupus News

Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis http://t.co/CUwfy21E #lupus

5 months ago...

Also Shared By:

MNT Neurology News MNT Neurology News

Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis http://t.co/ocVN4cNr

snsanalytics.com — “Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis http://t.co/ocVN4cNrView full resource at snsanalytics.com

  • View Related
  • Share

Most Recently Shared on November 17, 2011 at 12:55 pm By:

LupusLine Health Line Health Site

Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis http://t.co/ocVN4cNr

5 months ago...

Galenica.com - CellCept reaches positive results in Phase III trial in Lupus Nephritis

galenica.com — “Vifor Pharma, the pharma business sector of the Galenica Group, and Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the maintenance phase of the Aspreva Lupus Man-agement Study (ALMS) has successfully achieved its primary endpoint. The trial demonstrates the superiority of Roche's CellCept (mycophenolate mofetil) versus azathioprine (AZA) in de-laying treatment failure in patients with Lupus Nephritis (LN). ALMS is one of the largest stud-ies ever conducted in LN.View full resource at galenica.com

  • View Related
  • Share

Most Recently Shared on September 22, 2010 at 4:12 pm By:

LupusMD Lupus Doctor Internist, Rheumatologist, Physician, and Doctor

ALMSTrialCellCept vs AZA rx in patients who responded to CYT or AZA inductionMMF superior to AZA in delaying rx failure http://bit.ly/9f1pD0

2 years ago...

Advertisement